Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,133.15
+0.7%
$974.59
$623.78
$1,166.29
$1.07T0.532.99 million shs4.12 million shs
NVIDIA Corporation stock logo
NVDA
NVIDIA
$205.10
-6.2%
$203.37
$140.85
$236.54
$5.29T2.22166.84 million shs218.24 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$26.04
+1.4%
$26.62
$23.11
$28.75
$146.42B0.3431.71 million shs31.84 million shs
Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
+0.72%+2.51%+14.75%+14.39%+47.78%
NVIDIA Corporation stock logo
NVDA
NVIDIA
-6.20%-2.86%-1.49%+15.33%+44.52%
Pfizer Inc. stock logo
PFE
Pfizer
+1.34%-0.53%-1.76%-3.79%+11.20%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,133.15
+0.7%
$974.59
$623.78
$1,166.29
$1.07T0.532.99 million shs4.12 million shs
NVIDIA Corporation stock logo
NVDA
NVIDIA
$205.10
-6.2%
$203.37
$140.85
$236.54
$5.29T2.22166.84 million shs218.24 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$26.04
+1.4%
$26.62
$23.11
$28.75
$146.42B0.3431.71 million shs31.84 million shs
Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
+0.72%+2.51%+14.75%+14.39%+47.78%
NVIDIA Corporation stock logo
NVDA
NVIDIA
-6.20%-2.86%-1.49%+15.33%+44.52%
Pfizer Inc. stock logo
PFE
Pfizer
+1.34%-0.53%-1.76%-3.79%+11.20%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.87
Moderate Buy$1,227.008.28% Upside
NVIDIA Corporation stock logo
NVDA
NVIDIA
3.00
Buy$305.6749.03% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.20
Hold$28.8210.68% Upside

Current Analyst Ratings Breakdown

Latest PFE, LLY, and NVDA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/5/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Reiterated RatingOverweight
6/5/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
Initiated CoverageBuy$319.00
6/2/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
Reiterated RatingOutperform
6/2/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
Reiterated RatingBuy$270.00
6/1/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingNeutral
6/1/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
Reiterated RatingBuy$300.00
5/27/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
Reiterated RatingStrong-Buy$360.00 ➝ $425.00
5/27/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingNeutral$27.00
5/27/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
Boost Price TargetStrong-Buy$360.00 ➝ $425.00
5/26/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Boost Price TargetBuy$1,133.00 ➝ $1,251.00
5/26/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Set Price Target$1,119.00
(Data available from 6/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$72.25B14.77$25.32 per share44.76$28.07 per share40.37
NVIDIA Corporation stock logo
NVDA
NVIDIA
$215.94B22.99$4.43 per share46.29$8.08 per share25.38
Pfizer Inc. stock logo
PFE
Pfizer
$63.31B2.34$4.46 per share5.84$15.26 per share1.71
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$20.64B$28.1540.2525.431.2334.98%105.77%23.76%8/5/2026 (Estimated)
NVIDIA Corporation stock logo
NVDA
NVIDIA
$120.07B$6.5331.4117.760.4962.97%96.94%72.16%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$7.77B$1.3119.889.11N/A11.83%19.44%8.41%8/4/2026 (Estimated)

Latest PFE, LLY, and NVDA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/20/2026Q1 2027
NVIDIA Corporation stock logo
NVDA
NVIDIA
$1.76$1.87+$0.11$2.39$78.42 billion$81.62 billion
5/5/2026Q1 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.7220$0.75+$0.0280$0.47$13.84 billion$14.45 billion
4/30/2026Q1 2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.97$8.55+$1.58$8.26$17.82 billion$19.80 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.920.61%+15.18%24.58%11 Years
NVIDIA Corporation stock logo
NVDA
NVIDIA
$1.000.49%+14.87%15.31%1 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.60%-13.20%131.30%16 Years

Latest PFE, LLY, and NVDA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/20/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
quarterly$0.250.46%6/4/20266/4/20266/26/2026
4/22/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.436.71%5/8/20265/8/20266/12/2026
5/4/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
quarterly$1.730.69%5/15/20265/15/20266/10/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
1.26
1.50
1.10
NVIDIA Corporation stock logo
NVDA
NVIDIA
0.04
3.44
2.85
Pfizer Inc. stock logo
PFE
Pfizer
0.67
1.25
0.94

Institutional Ownership

CompanyInstitutional Ownership
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
82.53%
NVIDIA Corporation stock logo
NVDA
NVIDIA
65.27%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
0.14%
NVIDIA Corporation stock logo
NVDA
NVIDIA
3.94%
Pfizer Inc. stock logo
PFE
Pfizer
0.62%
CompanyEmployeesShares OutstandingFree FloatOptionable
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
50,000941.74 million940.42 millionOptionable
NVIDIA Corporation stock logo
NVDA
NVIDIA
42,00024.20 billion23.25 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
75,0005.70 billion5.66 billionOptionable

Recent News About These Companies

Watch Out for Hidden Risks
Pfizer (NYSE:PFE) Trading Up 1.4% - What's Next?
AbCellera Appoints Dr. Victor Sandor to its Board of Directors
Pfizer signs licence agreement with Chai for AI drug discovery

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Eli Lilly and Company stock logo

Eli Lilly and Company NYSE:LLY

$1,133.14 +7.88 (+0.70%)
Closing price 06/5/2026 03:59 PM Eastern
Extended Trading
$1,125.00 -8.14 (-0.72%)
As of 06/5/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

NVIDIA stock logo

NVIDIA NASDAQ:NVDA

$205.10 -13.56 (-6.20%)
Closing price 06/5/2026 04:00 PM Eastern
Extended Trading
$204.07 -1.03 (-0.50%)
As of 06/5/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. The Compute & Networking segment comprises Data Center computing platforms and end-to-end networking platforms, including Quantum for InfiniBand and Spectrum for Ethernet; NVIDIA DRIVE automated-driving platform and automotive development agreements; Jetson robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud software and services. The company's products are used in gaming, professional visualization, data center, and automotive markets. It sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, consumer internet companies, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.

Pfizer stock logo

Pfizer NYSE:PFE

$26.04 +0.35 (+1.37%)
Closing price 06/5/2026 03:59 PM Eastern
Extended Trading
$25.97 -0.08 (-0.29%)
As of 06/5/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.